about
sameAs
Virologic Tools for HCV Drug Resistance TestingSilymarin for HCV infectionFrom non-A, non-B hepatitis to hepatitis C virus cureDynamic range of hepatitis C virus RNA quantification with the Cobas Ampliprep-Cobas Amplicor HCV Monitor v2.0 assay.Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infectionInterferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutationsComparative analysis of translation efficiencies of hepatitis C virus 5' untranslated regions among intraindividual quasispecies present in chronic infection: opposite behaviors depending on cell typeAn Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing AntibodiesBasic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry.Hepatitis C virus infection can mimic type 1 (antinuclear antibody positive) autoimmune chronic active hepatitis.Unique NS5b hepatitis C virus gene sequence consensus database is essential for standardization of genotype determinations in multicenter epidemiological studies.Multicenter Quality Control for the Detection of Hepatitis C Virus RNA in Seminal Plasma SpecimensAlpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In VitroeuHCVdb: the European hepatitis C virus databaseAnalysis of Ribavirin Mutagenicity in Human Hepatitis C Virus InfectionMulticenter Trials Need To Use the Same Assay for Hepatitis C Virus Viral Load DeterminationInfluence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patternsSignificance of indeterminate third-generation hepatitis C virus recombinant immunoblot assaySerological determination of hepatitis C virus genotype: comparison with a standardized genotyping assaySignificance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBAPerformance of the Abbott Real-Time PCR Assay Using m2000sp and m2000rt for Hepatitis C Virus RNA QuantificationHepatitis C Virus Proteins Induce Lipogenesis and Defective Triglyceride Secretion in Transgenic MiceHepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical PracticeInhibition of RNA binding to hepatitis C virus RNA-dependent RNA polymerase: a new mechanism for antiviral interventionConsensus proposals for a unified system of nomenclature of hepatitis C virus genotypesRecent advances in understanding and diagnosing hepatitis B virus infectionInterferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infectionSystemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis CIP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infectionHepatitis C virus infection.Hepatitis C treatment: the data flood goes on-an update from the liver meeting 2014.Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activitiesPD-L1 expression in perihilar and intrahepatic cholangiocarcinoma.Expertise of French laboratories in detection, genotyping, and quantification of hepatitis C virus RNA in serumDirect-acting antiviral agents and the path to interferon independence.Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10.Diagnostic tests for hepatitis C.Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study.Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms.Molecular tools for the treatment of hepatitis C.
P50
Q26774374-4F30E7AC-50AE-48D5-B9D6-4876CF3F0818Q26851453-1B066120-B329-4E28-B8F6-6F3A2BC20050Q26864968-08695488-662D-48B1-B611-673914A81B02Q27469461-83C47665-1B38-4388-B2B4-DEDD57AE89B4Q27469507-1D31D992-86A5-40EA-92FB-AD5A6A27BFFBQ27469554-C0CE534F-7481-42A5-965B-54793E213ACAQ27469602-6F394655-CC20-44AB-81C0-65E4F08F82F2Q27469837-38CA73DD-1C06-4F59-83DA-C81674807252Q27472768-B8621AE8-E56B-45E5-952F-5CD84E8902FBQ27472993-48885BDC-87B9-4EF7-B161-1673E8999669Q27473035-02CBFA0D-61D0-47E5-AB21-A42EEAA4E82CQ27473329-B6007DAE-747E-42E4-90CB-5F8BB4DEC9CBQ27473519-5CDAA890-01A0-4EFE-AB3F-FC81681308EEQ27477695-3B52D56C-112E-49F2-889C-B0EDE48495A5Q27480933-6C07CE10-2661-4B55-9D62-CC15656F9C39Q27484906-2B4C7FC9-FC33-4F7E-8418-08D7563CEA8BQ27485653-E0EF4AA6-F28C-4DC3-8976-D075079225FDQ27485680-26ADAA6D-E37B-4ED4-8762-86369A669E57Q27485780-B1C86EAB-E4BD-4004-A524-77D328508A32Q27487871-E15BD7B3-20D0-4441-996F-345743E39D43Q27488563-810462B6-6E35-45FE-A608-2BF8628B2151Q27490446-FFA036CB-7FB7-4D7E-835B-4FDA506B70F3Q27490447-F6EBFC04-A54D-4827-9B88-34407E90CE9DQ27684795-A6505626-A209-49F3-BC27-D12BC5683D6BQ27861119-567A588F-3FF3-4B99-8A96-F91FC98AD5F9Q28067419-CB3704A7-321A-420B-84A9-073252CBE838Q28262594-8DF7FB31-E644-4374-855D-8EBCC77D649DQ28274298-6912781A-021A-4259-8C72-62F468E5DBE9Q28276247-888272FA-1E32-41FD-AD26-33B19B3CC8AAQ30235491-236B9FBE-C19E-43A9-BF1E-391EF77A50C2Q30883906-FC5ECC1B-5AB4-423C-B760-EE9691C82BC6Q31132161-5DC5DDA1-914C-4CD4-92DF-6C9E5B6EAA5CQ33648598-2B7EE0F7-31B2-4396-90B3-B7917A5287FCQ33712557-C0A26F2F-3A69-4A54-86F4-C622609954FAQ33727347-ADC96C0A-1695-4800-9EC0-6C35E85894FFQ33770890-37EB1126-9582-4B8E-B35A-AD9A1946A327Q33809460-F320BBE1-35E5-4A26-AE8B-DE80C3F8EC2DQ33825378-66EAF334-3136-4BC9-B152-36F241133181Q33842239-D1381FC3-1098-460A-9188-FF6EBEDBDB97Q33868396-3B012500-C78C-4D5E-B654-C523E456ABDE
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Jean-Michel Pawlotsky
@ast
Jean-Michel Pawlotsky
@en
Jean-Michel Pawlotsky
@es
Jean-Michel Pawlotsky
@nl
Jean-Michel Pawlotsky
@sl
type
label
Jean-Michel Pawlotsky
@ast
Jean-Michel Pawlotsky
@en
Jean-Michel Pawlotsky
@es
Jean-Michel Pawlotsky
@nl
Jean-Michel Pawlotsky
@sl
prefLabel
Jean-Michel Pawlotsky
@ast
Jean-Michel Pawlotsky
@en
Jean-Michel Pawlotsky
@es
Jean-Michel Pawlotsky
@nl
Jean-Michel Pawlotsky
@sl
P214
P106
P21
P213
0000 0003 5861 2125
P214
P31
P4124
jean-michel-pawlotsky_67736
P496
0000-0003-0745-7559
P569
2000-01-01T00:00:00Z
P735
P7859
lccn-nb2007017167